antituberculosis drug

antituberculosis drug

Infectious disease Any drug–eg, isoniazid, rifampin, ethambutol, streptomycin, pyrazinamide, ethionamide, para-aminosalicylic acid, kanamycin, cycloserine, capreomycin, ciprofloxacin, amikacin, used to manage TB; multidrug-resistant isolates of M tuberculosis are most often resistant to isoniazid and rifampin. See Drug-resistant tuberculosis.
References in periodicals archive ?
Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa--an upward trend.
The patient was started on antituberculosis drug therapy, but he died within 2 weeks of treatment.
World Health Organization, WHO-IUTALD Global Project on AntiTuberculosis Drug Resistance Surveillance.
The diagnosis of primary nasal tuberculosis was established only after we obtained the results of histopathology of the excised mass and a subsequent tuberculin skin test; the diagnosis was confirmed by the patient's rapid response to antituberculosis drug therapy.
tuberculosis strains differed in their capacity to withstand antituberculosis drug treatment.
Chapter 1 provides updated information from a survey of the network of supranational reference laboratories to determine the prevalence of XDR-TB among strains sent for drug susceptibility testing (DST) in addition to new data from the WHO/IUATLD Global Project on Antituberculosis Drug Resistance Surveillance.
Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on antituberculosis drug resistance surveillance.
Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.
Mutation frequency of Mycobacterium tuberculosis genotype strains originating from Vietnam, by antituberculosis drug Frequency of mutation among strains * Genotype Isoniazid Beijing 1585 5.
Global Project on Antituberculosis Drug Resistance Surveillance: Antituberculosis drug resistance in the world.
In a previous survey, conducted in Taiwan during 2000-2008, we found the rate of antituberculosis drug resistance to be lower for older patients than for younger patients (2); however, current information about the patient characteristics associated with isoniazid-resistant tuberculosis (TB) in Taiwan is lacking.
Antituberculosis drug resistance in western Canada (1993 to 1994).